Technical Analysis for AZN - Astrazeneca PLC

Grade Last Price % Change Price Change
grade A 42.59 -0.77% -0.33
AZN closed down 0.77 percent on Friday, March 22, 2019, on 76 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical AZN trend table...

Date Alert Name Type % Chg
Mar 22 Slingshot Bullish Bullish Swing Setup 0.00%
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 22 Gapped Down Weakness 0.00%
Mar 21 Shooting Star Candlestick Bearish -0.77%
Mar 21 Lizard Bearish Bearish Day Trade Setup -0.77%
Mar 21 Bollinger Band Squeeze Range Contraction -0.77%
Mar 21 Doji - Bearish? Reversal -0.77%
Mar 21 BB Squeeze + Upper Band Touch Range Contraction -0.77%
Mar 21 Overbought Stochastic Strength -0.77%

Older signals for AZN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for cardiovascular, gastrointestinal, neuroscience, infection, oncology, and respiratory and inflammation diseases worldwide. Its principal products include Atacand for hypertension and heart failure; Crestor for managing cholesterol levels; Seloken/Toprol-XL for hypertension, heart failure, and angina; Nexium for acid reflux; Synagis for RSV, a respiratory infection in infants; Seroquel IR for schizophrenia and bipolar disorders; and Seroquel XR for schizophrenia, bipolar disorder, and major depressive disorders. The company principal products also comprise Zoladex for prostate and breast cancer; Pulmicort for asthma and chronic obstructive pulmonary diseases; and Symbicort for asthma and chronic obstructive pulmonary diseases. In addition, it has 84 pipeline projects, which include 71 projects in various clinical phases of development. The company markets its products to primary care and specialist doctors through distributors or local representative offices. AstraZeneca PLC has collaboration agreements with Amgen, Inc. to develop and commercialize monoclonal antibodies; Ironwood Pharmaceuticals, Inc to co-develop and co-commercialize linaclotide in China; BIND Therapeutics, Inc. to develop and commercialize cancer nanomedicine; and WuXi AppTec to develop and commercialize MEDI5117, a biologic for autoimmune and inflammatory diseases. It also has a strategic alliance with Isis Pharmaceuticals, Inc. for the discovery and development of novel generation antisense therapeutics; and a strategic collaboration with FibroGen, Inc. to develop and commercialize FG-4592, a compound for the treatment of anemia associated with chronic kidney disease and end-stage renal disease. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in London, the United Kingdom.
Cancer Drugs Antibodies Monoclonal Antibodies Infection Breast Cancer Neuroscience Schizophrenia Asthma Chronic Kidney Disease Hypertension Heart Failure Psychoactive Drugs Anemia End Stage Renal Disease Isis Astrazeneca Autoimmune And Inflammatory Diseases Pulmonology Bipolar Disorder Chronic Obstructive Pulmonary Diseases Major Depressive Disorders Södertälje Municipality Angina Bipolar Disorders Chronic Condition Ironwood Pharmaceuticals Quetiapine Respiratory Disease
Is AZN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 43.29
52 Week Low 34.29
Average Volume 5,143,075
200-Day Moving Average 38.3927
50-Day Moving Average 39.2484
20-Day Moving Average 42.195
10-Day Moving Average 42.525
Average True Range 0.5882
ADX 39.75
+DI 38.0841
-DI 17.726
Chandelier Exit (Long, 3 ATRs ) 41.5254
Chandelier Exit (Short, 3 ATRs ) 41.9046
Upper Bollinger Band 43.1085
Lower Bollinger Band 41.2815
Percent B (%b) 0.72
BandWidth 4.329897
MACD Line 0.9282
MACD Signal Line 1.0184
MACD Histogram -0.0902
Fundamentals Value
Market Cap 107.84 Billion
Num Shares 2.53 Billion
EPS 1.52
Price-to-Earnings (P/E) Ratio 28.02
Price-to-Sales 3.91
Price-to-Book 6.22
PEG Ratio 2.37
Dividend 0.90
Dividend Yield 2.11%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 43.25
Resistance 3 (R3) 43.27 43.06 43.14
Resistance 2 (R2) 43.06 42.90 43.06 43.10
Resistance 1 (R1) 42.83 42.79 42.95 42.81 43.07
Pivot Point 42.62 42.62 42.68 42.62 42.62
Support 1 (S1) 42.39 42.46 42.51 42.37 42.11
Support 2 (S2) 42.18 42.35 42.18 42.08
Support 3 (S3) 41.95 42.18 42.04
Support 4 (S4) 41.93